David Lum

9PUBLICATIONS
129CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 10, 2026
Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis.

|Jun 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

|Apr 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

|Jul 01, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Eric A Smith, Rachel L Belote, Nelly M Cruz

|Jun 18, 2024
Zinc-alpha-2-glycoprotein Secreted by Triple-Negative Breast Cancer Promotes Peritumoral Fibrosis.

Surbhi Verma, Stephanie D Giagnocavo, Meghan C Curtin

|Dec 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.

Yige Wu, Siqi Chen, Xiaolu Yang

Pageof 2

Frequent Collaborators

3 joint publications

Alana L Welm

2 joint publications

Kevin B Jones

2 joint publications

Jeffrey H Chuang

2 joint publications

Bryan E Welm